help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 34, No. 3 531-536
doi:10.1210/jcem-34-3-531
Copyright © 1972 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPEROFF, L.
Right arrow Articles by HOBBINS, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPEROFF, L.
Right arrow Articles by HOBBINS, J. C.

Hormone Levels During Prostaglandin F2{alpha} Infusions for Therapeutic Abortion

LEON SPEROFF, BURTON V. CALDWELL, WILLIAM A. BROCK, GERALD G. ANDERSON and JOHN C. HOBBINS

Department of Obstetrics and Gynecology, Yale University School of Medicine New Haven, Connecticut 06510

Plasma levels of unconjugated estrone, 17β-estradiol, estriol, progesterone, 17-hydroxyprogesterone, human chorionic gonadotropin (HCG), and human chorionic somatomammotropin (HCS) were measured in patients 7–20 weeks pregnant receiving prostaglandin F2{alpha} infusions for therapeutic abortions. The results indicate that prostaglandin F2{alpha} a does not exert a luteolytic effect in terminating pregnancy of 7 weeks or more duration. Significant progesterone changes were not seen prior to abortion, and no effect was seen on 17-hydroxyprogesterone levels. There was a gradual decline in estradiol levels during prostaglandin F2{alpha} infusion, while significant falls were seen in estriol levels preceding any changes in estradiol or progesterone. There were no significant changes in HCG levels, while HCS levels declined during the infusion. The data do not rule out the possibility of a luteolytic effect for prostaglandin F2{alpha} in the first few weeks of pregnancy.

Received April 27, 1971.




This article has been cited by other articles:


Home page
ScienceHome page
C. Murty and P. Adiga
Pregnancy suppression by active immunization against gestation-specific riboflavin carrier protein
Science, April 9, 1982; 216(4542): 191 - 193.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
H. R. Behrman and G. G. Anderson
Prostaglandins in Reproduction
Arch Intern Med, January 1, 1974; 133(1): 77 - 84.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1972 by The Endocrine Society